Log in

Relevant bibliographies by topics / AIDS (Disease) / Journal articles

Journal articles on the topic 'AIDS (Disease)'

To see the other types of publications on this topic, follow the link: AIDS (Disease).

Author: Grafiati

Published: 4 June 2021

Last updated: 10 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'AIDS (Disease).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Thomsen, Hauke, Xinjun Li, Kristina Sundquist, Jan Sundquist, Asta Försti, and Kari Hemminki. "Familial associations for Addison’s disease and between Addison’s disease and other autoimmune diseases." Endocrine Connections 9, no. 11 (November 2020): 1114–20. http://dx.doi.org/10.1530/ec-20-0328.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Abstract:

Design Addison’s disease (AD) is a rare autoimmune disease (AID) of the adrenal cortex, present as an isolated AD or part of autoimmune polyendocrine syndromes (APSs) 1 and 2. Although AD patients present with a number of AID co-morbidities, population-based family studies are scarce, and we aimed to carry out an unbiased study on AD and related AIDs. Methods We collected data on patients diagnosed with AIDs in Swedish hospitals and calculated standardized incidence ratios (SIRs) in families for concordant AD and for other AIDs, the latter as discordant relative risks. Results The number of AD patients was 2852, which accounted for 0.4% of all hospitalized AIDs. A total of 62 persons (3.6%) were diagnosed with familial AD. The SIR for siblings was remarkably high, reaching 909 for singleton siblings diagnosed before age 10 years. It was 32 in those diagnosed past age 29 years and the risk for twins was 323. SIR was 9.44 for offspring of affected parents. AD was associated with 11 other AIDs, including thyroid AIDs and type 1 diabetes and some rarer AIDs such as Guillain–Barre syndrome, myasthenia gravis, polymyalgia rheumatica and Sjögren’s syndrome. Conclusions The familial risk for AD was very high implicating genetic etiology, which for juvenile siblings may be ascribed to APS-1. The adult part of sibling risk was probably contributed by recessive polygenic inheritance. AD was associated with many common AIDs; some of these were known co-morbidities in AD patients while some other appeared to more specific for a familial setting.

2

Kamradt, T., D. Niese, and F. Vogel. "SLIM DISEASE (AIDS)." Lancet 326, no. 8469-8470 (December 1985): 1425. http://dx.doi.org/10.1016/s0140-6736(85)92588-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Marquart, K. H., H. A. G. Müller, J. Sailer, and R. Moser. "SLIM DISEASE (AIDS)." Lancet 326, no. 8465 (November 1985): 1186–87. http://dx.doi.org/10.1016/s0140-6736(85)92707-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Chen, Yahong, Jinjin Yuan, Xianlin Han, Xiaolong Liu, Xiao Han, and Hanhui Ye. "Coexpression Analysis of Transcriptome on AIDS and Other Human Disease Pathways by Canonical Correlation Analysis." International Journal of Genomics 2017 (2017): 1–10. http://dx.doi.org/10.1155/2017/9163719.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Abstract:

Acquired immune deficiency syndrome is a severe disease in humans caused by human immunodeficiency virus. Several human genes were characterized as host genetic factors that impact the processes of AIDS disease. Recent studies on AIDS patients revealed a series disease is complicating with AIDS. To resolve gene interaction between AIDS and complicating diseases, a canonical correlation analysis was used to identify the global correlation between AIDS and other disease pathway genes expression. The results showed that HLA-B, HLA-A, MH9, ZNED1, IRF1, TLR8, TSG101, NCOR2, and GML are the key AIDS-restricted genes highly correlated with other disease pathway genes. Furthermore, pathway genes in several diseases such as asthma, autoimmune thyroid disease, and malaria were globally correlated with ARGs. It suggests that these diseases are a high risk in AIDS patients as complicating diseases.

5

Simon, Douglas, and Lawrence J. Brandt. "Biliary tract disease in aids: Aids vs. nonaids." Hepatology 12, no. 3 (September 1990): 618–19. http://dx.doi.org/10.1002/hep.1840120330.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

McGuinness, G., J. F. Gruden, M. Bhalla, T. J. Harkin, J. S. Jagirdar, and D. P. Naidich. "AIDS-related airway disease." American Journal of Roentgenology 168, no. 1 (January 1997): 67–77. http://dx.doi.org/10.2214/ajr.168.1.8976923.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Golbus, Joseph. "Rheumatic disease and AIDS." Postgraduate Medicine 92, no. 4 (September 15, 1992): 99–110. http://dx.doi.org/10.1080/00325481.1992.11701468.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

McGowan, Ian, and Peter Anton. "AIDS and intestinal disease." Current Opinion in Gastroenterology 13, no. 1 (January 1997): 18–23. http://dx.doi.org/10.1097/00001574-199701000-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Metze, K., and J. A. Maciel. "AIDS and Chagas' disease." Neurology 43, no. 2 (February 1, 1993): 447. http://dx.doi.org/10.1212/wnl.43.2.447-a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Rieve, Julia A. "AIDS Disease Management Programs." Case Manager 11, no. 5 (September 2000): 38–39. http://dx.doi.org/10.1067/mcm.2000.110320.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Goodman, Philip C. "Mycobacterial disease in AIDS." Journal of Thoracic Imaging 6, no. 4 (September 1991): 22–27. http://dx.doi.org/10.1097/00005382-199109000-00007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Navarro, Willis H., and Lawrence D. Kaplan. "AIDS-related lymphoproliferative disease." Blood 107, no. 1 (January 1, 2006): 13–20. http://dx.doi.org/10.1182/blood-2004-11-4278.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Abstract:

Abstract Not long after the recognition of HIV as the causative agent of AIDS, it was evident that individuals infected with HIV developed lymphoma at a greater rate than the population at large. Approximately two thirds of AIDS-related lymphoma (ARL) cases are categorized as diffuse large B-cell type, with Burkitt lymphomas comprising 25% and other histologies a much smaller proportion. Typically, these individuals have presented with advanced extranodal disease and CD4+ lymphocyte counts of less than 200/mm3. Recent clinical trials have demonstrated a better outcome with chemotherapy for ARL since the introduction of combination antiretroviral treatment, termed highly active antiretroviral therapy (HAART). For patients with relapses, solid evidence points to the safety and utility of hematopoietic-cell transplantation as a salvage modality. Coinfection with other viruses such as Epstein-Barr virus and Kaposi sarcoma-associated herpesvirus have led to the genesis of previously rare or unrecognized lymphoma subtypes such as plasmablastic and primary effusion lymphomas. The immunosuppressive impact of treatment for patients with ARL receiving chemotherapy with HAART appears transient and opportunistic infections have become less problematic than prior to HAART. Significant progress has been made in the understanding and management of ARL but outcomes still remain inferior compared to those achieved in HIV- individuals.

13

Pinto, Amélia Nogueira. "AIDS and Cerebrovascular Disease." Stroke 27, no. 3 (March 1996): 538–43. http://dx.doi.org/10.1161/01.str.27.3.538.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Williams, Jennet, and Mark Bower. "AIDS-related malignant disease." Medicine 41, no. 8 (August 2013): 430–34. http://dx.doi.org/10.1016/j.mpmed.2013.05.013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Dalla Pria, Alessia, and Mark Bower. "AIDS-related malignant disease." Medicine 46, no. 6 (June 2018): 365–69. http://dx.doi.org/10.1016/j.mpmed.2018.03.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Mönkemüller, Klaus E., and Martín Olmos. "Gastric disease in AIDS." Techniques in Gastrointestinal Endoscopy 4, no. 2 (April 2002): 66–70. http://dx.doi.org/10.1053/tgie.2002.33013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Ames, Elizabeth D., Michael S. Conjalka, Arthur F. Goldberg, Richard Hirschman, Sushil Jain, Ariel Distenfeld, and Craig E. Metroka. "Hodgkin's Disease and AIDS." Hematology/Oncology Clinics of North America 5, no. 2 (April 1991): 343–56. http://dx.doi.org/10.1016/s0889-8588(18)30446-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Lopez-Herce Cid, JoseAndres, Jesus Lopez-Herce Cid, EduardoFlores Sañudo, Javier Menarguez, and JaimeCosin Ochaita. "AIDS AND HODGKIN'S DISEASE." Lancet 328, no. 8515 (November 1986): 1104–5. http://dx.doi.org/10.1016/s0140-6736(86)90510-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Temple, J. J., and W. Abe Andes. "AIDS AND HODGKIN'S DISEASE." Lancet 328, no. 8504 (August 1986): 454–55. http://dx.doi.org/10.1016/s0140-6736(86)92155-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Kuo, Irene, and Narsing A. Rao. "Ocular disease in AIDS." Springer Seminars in Immunopathology 21, no. 2 (June 1999): 161–77. http://dx.doi.org/10.1007/bf00810248.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Kuo, Irene, and Narsing A. Rao. "Ocular disease in AIDS." Springer Seminars in Immunopathology 21, no. 2 (July 26, 1999): 161–77. http://dx.doi.org/10.1007/s002810050060.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Peppercorn, Mark A. "Anorectal disease in AIDS." Gastroenterology 104, no. 6 (June 1993): 1883. http://dx.doi.org/10.1016/0016-5085(93)90684-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Collins, Frank M. "AIDS-related mycobacterial disease." Springer Seminars in Immunopathology 10, no. 4 (December 1988): 375–91. http://dx.doi.org/10.1007/bf02053847.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Corti, Marcelo. "AIDS and Chagas' Disease." AIDS Patient Care and STDs 14, no. 11 (November 2000): 581–88. http://dx.doi.org/10.1089/10872910050193752.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Ives, David V. "Cytomegalovirus disease in AIDS." AIDS 11, no. 15 (December 1997): 1791–97. http://dx.doi.org/10.1097/00002030-199715000-00002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Berger, Joseph R., Jonathan O. Harris, Jocelyn Gregoriost, and Michael Norenbergt. "Cerebrovascular disease in AIDS." AIDS 4, no. 3 (March 1990): 239–44. http://dx.doi.org/10.1097/00002030-199003000-00010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Nyamathi, Adeline. "AIDS-related heart disease." Journal of Cardiovascular Nursing 3, no. 4 (August 1989): 65–76. http://dx.doi.org/10.1097/00005082-198908000-00009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Brettman, Lee R. "Liver disease in aids." Hepatology 7, no. 2 (March 1987): 403–5. http://dx.doi.org/10.1002/hep.1840070238.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Wilcox, C. Mel, and Klaus E. Mönkemüller. "Hepatobiliary Diseases in Patients with AIDS: Focus on AIDS Cholangiopathy and Gallbladder Disease." Digestive Diseases 16, no. 4 (1998): 205–13. http://dx.doi.org/10.1159/000016868.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Valenti, William M. "Update on AIDS." Infection Control 6, no. 2 (February 1985): 85–86. http://dx.doi.org/10.1017/s0195941700062664.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Abstract:

Recent advances in our knowledge of the Acquired Immune Deficiency Syndrome (AIDS) could have a major impact on practitioners in both infection control and employee health. The discovery that a retrovirus, the human T-cell leukemia virus (HTLV-III) is the cause of AIDS could be used to help health care workers better understand this disease. Those of us who are trying to provide our employees with up-to-date information on AIDS should use this new information to help employees understand the nature of the disease, its transmissibility and non-transmissibility. Now that the disease can be linked to a specific agent, employees may find AIDS to be much less mysterious. The retrovirus link is a major step forward in understanding this disease and may eventually lead to more effective treatment and possibly a vaccine. Our knowledge continues to evolve in much the same way as our understanding of Legionnaires' Disease and Toxic Shock Syndrome.The Acquired Immune Deficiency Syndrome (AIDS) was discussed extensively at recent infectious diseases meetings in Washington, D.C. The results of original research conducted by investigators at the National Institutes of Health (NIH), Centers for Disease Control (CDC), Pasteur Institute in Paris, and medical centers throughout the world were presented at the meetings. A number of issues have been clarified and the pieces of the puzzle are starting to come together.

31

Samuels, Hadas, Malki Malov, Trishna Saha Detroja, Karin Ben Zaken, Naamah Bloch, Meital Gal-Tanamy, Orly Avni, Baruh Polis, and Abraham O. Samson. "Autoimmune Disease Classification Based on PubMed Text Mining." Journal of Clinical Medicine 11, no. 15 (July 26, 2022): 4345. http://dx.doi.org/10.3390/jcm11154345.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Abstract:

Autoimmune diseases (AIDs) are often co-associated, and about 25% of patients with one AID tend to develop other comorbid AIDs. Here, we employ the power of datamining to predict the comorbidity of AIDs based on their normalized co-citation in PubMed. First, we validate our technique in a test dataset using earlier-reported comorbidities of seven knowns AIDs. Notably, the prediction correlates well with comorbidity (R = 0.91) and validates our methodology. Then, we predict the association of 100 AIDs and classify them using principal component analysis. Our results are helpful in classifying AIDs into one of the following systems: (1) gastrointestinal, (2) neuronal, (3) eye, (4) cutaneous, (5) musculoskeletal, (6) kidneys and lungs, (7) cardiovascular, (8) hematopoietic, (9) endocrine, and (10) multiple. Our classification agrees with experimentally based taxonomy and ranks AID according to affected systems and gender. Some AIDs are unclassified and do not associate well with other AIDs. Interestingly, Alzheimer’s disease correlates well with other AIDs such as multiple sclerosis. Finally, our results generate a network classification of autoimmune diseases based on PubMed text mining and help map this medical universe. Our results are expected to assist healthcare workers in diagnosing comorbidity in patients with an autoimmune disease, and to help researchers in identifying common genetic, environmental, and autoimmune mechanisms.

32

Janaki, CR, GS Selvi, B. Parveen, N. Gomathy, and Anupama Roshan. "AIDS defining disease: Disseminated cryptococcosis." Indian Journal of Dermatology 51, no. 3 (2006): 202. http://dx.doi.org/10.4103/0019-5154.27988.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Northup, George W. "AIDS: Disease of the 80s." Journal of the American Osteopathic Association 85, no. 11 (November 1, 1985): 46–47. http://dx.doi.org/10.1515/jom-1985-851110.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Silberner, J. "AIDS: Disease, Research Efforts Advance." Science News 127, no. 17 (April 27, 1985): 260. http://dx.doi.org/10.2307/3969504.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Ryder, Mark I., Wipawee Nittayananta, Maeve Coogan, Deborah Greenspan, and John S. Greenspan. "Periodontal disease in HIV/AIDS." Periodontology 2000 60, no. 1 (August 22, 2012): 78–97. http://dx.doi.org/10.1111/j.1600-0757.2012.00445.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Lewis, Laurie. "AIDS as a Chronic Disease." AIDS Patient Care 3, no. 3 (June 1989): 28–30. http://dx.doi.org/10.1089/apc.1989.3.28.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Faria, PR, PA Vargas, PHN Saldiva, GM Böhm, T. Mauad, and OP Almeida. "Tongue disease in advanced AIDS." Oral Diseases 11, no. 2 (March 2005): 72–80. http://dx.doi.org/10.1111/j.1601-0825.2004.01070.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Cello, John P. "AIDS-Related Biliary Tract Disease." Gastrointestinal Endoscopy Clinics of North America 8, no. 4 (October 1998): 963–73. http://dx.doi.org/10.1016/s1052-5157(18)30242-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Yu, Qianli, Douglas F. Larson, and Ronald R. Watson. "Heart disease, methamphetamine and AIDS." Life Sciences 73, no. 2 (May 2003): 129–40. http://dx.doi.org/10.1016/s0024-3205(03)00260-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Yeager, Barbara. "AIDS not an infectious disease?" Geriatric Nursing 12, no. 1 (January 1991): 4. http://dx.doi.org/10.1016/s0197-4572(06)80299-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Freeman, William R. "Retinal disease associated with AIDS*." Australian and New Zealand Journal of Ophthalmology 21, no. 2 (May 1993): 71–78. http://dx.doi.org/10.1111/j.1442-9071.1993.tb00757.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Kohan, Darius, Paul E. Hammerschlag, and Roy A. Holliday. "Otologic Disease in AIDS Patients." Laryngoscope 100, no. 12 (December 1990): 1326???1330. http://dx.doi.org/10.1288/00005537-199012000-00016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Enns, R. "AIDS cholangiopathy: “an endangered disease”." American Journal of Gastroenterology 98, no. 10 (October 2003): 2111–12. http://dx.doi.org/10.1016/s0002-9270(03)00757-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Kelly, R. D. "AIDS: Therapeutics in HIV Disease." Biochemical Education 16, no. 4 (October 1988): 238. http://dx.doi.org/10.1016/0307-4412(88)90146-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Pratt, Robert J. "AIDS—Therapeutics in HIV disease." International Journal of Nursing Studies 26, no. 1 (January 1989): 84. http://dx.doi.org/10.1016/0020-7489(89)90052-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Weissler, Jonathan C., and Ann R. Mootz. "Pulmonary Disease in AIDS Patients." American Journal of the Medical Sciences 300, no. 5 (November 1990): 330–43. http://dx.doi.org/10.1097/00000441-199011000-00010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Lowe, G. D. O. "AIDS—therapeutics of HIV disease." Fibrinolysis 2, no. 4 (October 1988): 259. http://dx.doi.org/10.1016/0268-9499(88)90022-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Enns, Robert. "AIDS cholangiopathy: "an endangered disease"." American Journal of Gastroenterology 98, no. 10 (October 2003): 2111–12. http://dx.doi.org/10.1111/j.1572-0241.2003.07724.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Brettle, R. P. "AIDS therapeutics in HIV disease." Sexually Transmitted Infections 64, no. 6 (December 1, 1988): 398. http://dx.doi.org/10.1136/sti.64.6.398-b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Coleman, D. G., E. J. Beck, B. S. Peters, J. R. Harris, and A. J. Pinching. "Changing disease patterns in AIDS." BMJ 304, no. 6830 (March 28, 1992): 839. http://dx.doi.org/10.1136/bmj.304.6830.839-a.

Full text

APA, Harvard, Vancouver, ISO, and other styles